Gahyun Kim

Ms. Gahyun Kim

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GKGahyun Kim
Gahyun Kim
BKBo Mi Kim
Bo Mi Kim
Peptides are notable cosmetic ingredients owing to their diverse biological activities and beneficial effects on skin health. Therefore, multifunctional peptides capable of simultaneously exerting antioxidant, whitening, and anti-wrinkle effects are highly desirable. In this study, a scalable and cost-effective chemical synthesis strategy was used for the rapid design and synthesis of linear peptide sequences with skin bioactivity using solid-phase peptide synthesis. Subsequently, liquid-phase peptide synthesis was used to enhance the proteolytic stability and develop a cyclic peptide, cyclic CYGSR (CR5), which was subjected to in vitro biological evaluation. CR5 showed high biocompatibility in water-soluble tetrazolium salt-1 (WST-1) assays, maintaining over 90% cell viability at concentrations up to 400 μg/mL. In the 2,2-Diphenyl-1-picrylhydrazy (DPPH) assay, CR5 exhibited strong antioxidant activity with 83.18% radical scavenging at 200 μg/mL. It also showed 97.79% tyrosinase inhibition at 800 μg/mL, confirming significant whitening potential. Moreover, CR5 inhibited matrix metalloproteinase-1 (MMP-1) expression by 73.55% and increased type I procollagen expression by 44.68% at 400 μg/mL, demonstrating its anti-wrinkle potential. Additionally, molecular docking and dynamic simulation demonstrated stable binding of the peptide to tyrosinase and MMP-1. Collectively, CR5 possesses multifunctional properties with excellent biocompatibility, highlighting its potential as a novel cosmetic active ingredient.

12 January 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
GKGahyun Kim
Gahyun Kim
JBJeong-Eun Bang
Jeong-Eun Bang
BKBo Mi Kim
Bo Mi Kim
Peptide cyclization is a strategy to improve biological stability and functional activity, but direct comparison between linear and cyclic peptides with the same sequence is still limited. In this study, linear (L-CR5) and cyclic (C-CR5) forms were synthesized, and biological functions such as antioxidant, whitening, and anti-wrinkle activity were compared and evaluated. C-CR5 showed about 22.3 times of DPPH radical scavenging activity, which was significantly stronger than L-CR5, and tyrosinase inhibition increased rapidly in C-CR5 to reach inhibition of 95% or more, whereas L-CR5 showed only moderate activity in the same range (about 6.5 times). MMP-1 expression in the evaluation of anti-wrinkle activity did not show a decreasing trend in L-CR5 at all, while C-CR5 showed an anti-wrinkle effect, which was reduced by about 92.8% at 400 μg/mL. As a result of molecular docking analysis, C-CR5 exhibited lower MolDock scores than L-CR5 toward both tyrosinase and MMP-1, indicating a potentially higher binding affinity and improved binding stability. This is expected to be due to reduced structural flexibility and optimized residue directions (especially Tyr and Arg). These results indicate that peptide cyclization is an example of enhanced functional bioactivity of CYGSR and provides a positive case for the structure–activity relationship.

13 June 2026 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Open access
PDF file
GKGahyun Kim
Gahyun Kim
JBJeong-Eun Bang
Jeong-Eun Bang
BKBo Mi Kim
Bo Mi Kim
Purpose Excessive melanin production causes various pigmentary disorders, and strategies involving tyrosinase inhibition and antioxidant activity are crucial for regulating this process. Methods In this study, we designed and synthesized CV5, a short head-to-tail cyclic peptide, and evaluated its structural characteristics and biological activity. Results CV5 exhibited excellent biocompatibility with a purity of over 98% and no cytotoxicity. Furthermore, it exhibited tyrosinase inhibitory activity approximately 1.6 times higher than that of arbutin (IC₅₀: 336.7 ± 5.79 µM) and demonstrated antioxidant effects that were 1.6-fold and 1.8-fold superior to the two control groups in DPPH and ABTS radical scavenging assays, respectively (IC₅₀: 30.27 ± 1.06 µM, 282.4 ± 11.45 µM). Molecular docking analysis confirmed the potential for interaction with the enzyme’s active site. Conclusion These results suggest that a natural amide-based cyclization strategy can overcome the biocompatibility and metabolic limitations associated with peptidomimics incorporating non-natural skeletons, and validate CV5 as a potential candidate for the treatment of pigmentary disorders and the promotion of skin health.